secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001104659-24-127477
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape Lifesciences announces pending merger with Vyome Therapeutics; ticker to change to $HIND
--------------------------------------------------------------------------------

- Merger with Vyome Therapeutics Inc. and asset sale to Biorad Medisys or affiliate.
- Ticker symbol to change from RSLS to HIND upon closing.
- Investor presentation furnished as Exhibit 99.1, highlighting clinical-stage immunoinflammation assets.
- No specific deal value or premium disclosed in this filing.
- Approval required from ReShape stockholders; joint proxy statement/prospectus to be filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465924127477/0001104659-24-127477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465924127477/tm2430703d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-127477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer